
Advertise on podcast: The Retina Channel Podcast
Rating
4.5from
This podcast has
99 episodes
Language
EnglishPublisher
Keyvan Koushan, MD, FRCSCExplicit
No
Date created
2017/10/23
Latest episode
2026/10/31
Average duration
40 min.
Release period
43 days
Description
A journal club to review recent journal articles in the field of retina. The target audience are retina specialists and other healthcare professionals who want to stay up-to-date with the latest publications in the field of retina.
Unlock The Retina Channel Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from The Retina Channel Podcast podcast
E99-The Art of Retinal Detachment Repair with Dr. Mrinali Gupta
2026/10/31
In this episode of The Retina Channel Podcast, Dr. Mrinali Gupta joins me for a practical, case-based discussion on retinal detachment surgery. We start with an inferior retinal detachment in a pseudophakic patient and debate vitrectomy versus scleral buckle, before diving into vitreous shaving, tamponade selection, postoperative positioning, and the role of 360-degree laser. We discuss when scleral buckling still has an important role in modern retinal detachment repair and when to combine a buckle with vitrectomy. We then tackle more complex surgical scenarios, including PVR and diabetic tractional retinal detachments, with practical insights on preoperative anti-VEGF, membrane peeling, and surgical decision-making in these challenging cases.
E98-Inherited Retinal Diseases in 2026 - Dr. Brian Ballios
2026/08/28
Dr. Brian Ballios from the University of Toronto and Toronto Western Hospital returns to The Retina Channel for a comprehensive update on inherited retinal diseases (IRDs). We discuss the evolving landscape of gene therapy, including long-term experience with RPE65 therapy and emerging treatments for IRDs including antisense oligonucleotides, optogenetics, new therapies for Stargardt disease, stem cell and photoreceptor replacement strategies, and the importance of natural history studies in designing future clinical trials. Brian was the second-ever guest on The Retina Channel back in 2017, making his return for Episode 98 nearly nine years later a particularly special one. A fascinating discussion about how far the field has come — and where IRD treatment may be heading next.
E97- Artificial Intelligence in Ophthalmology- Dr. John Kitchens
2026/06/15
In this episode of The Retina Channel Podcast, Dr. Keyvan Koushan sits down with renowned retina specialist John Kitchens to discuss the rapidly evolving role of artificial intelligence in ophthalmology and medicine. Dr. Kitchens shares his practical experience using AI platforms such as ChatGPT, Claude, Gemini, and Perplexity, offering insights into how these tools can enhance clinical practice, education, research, communication, and everyday productivity. The conversation explores both the opportunities and limitations of AI, provides real-world examples of its use in ophthalmology, and offers a thoughtful look at how physicians can prepare for a future increasingly shaped by intelligent technologies. Whether you're an AI enthusiast or just beginning to explore these tools, this episode offers a practical and engaging perspective on one of the most important technological shifts in modern medicine.
E96- Tonabersat for DME- DRCR Protocol AN- Dr. Jennifer Sun
2026/05/18
In this episode of The Retina Channel Podcast, Dr. Jennifer Sun joins Dr. Keyvan Koushan to discuss the Phase 2 results of DRCR Retina Network Protocol AN evaluating tonabersat for diabetic macular edema. Dr. Sun reviews the rationale behind targeting connexin-43–mediated inflammatory pathways in DME, the key efficacy and safety findings from the study, and the potential implications of this novel oral therapy for future diabetic retinal disease management. The conversation also explores broader trends in DRCR clinical research and emerging treatment paradigms in diabetic eye disease.
E95- Real-World Data of Intraocular Inflammation Associated with Faricimab- Dr. Andrea Montesel
2026/03/21
E94 – Systemic Drugs & Underrecognized Maculopathy - Dr. Seong Joon Ahn
2026/01/23
In this episode of The Retina Channel Podcast, I sit down with Dr. Seong Joon Ahn from Hanyang University in South Korea to discuss a recent JAMA Ophthalmology study examining systemic drugs associated with underrecognized maculopathy. Using a novel two-step approach that integrates pharmacovigilance signal detection from the FDA Adverse Event Reporting System (FAERS) with nationwide health-claims data from South Korea, the study identifies several commonly used systemic medications— apixaban, paclitaxel, ibrutinib, fingolimod, and sildenafil—as being associated with an increased risk of maculopathy. We explore the study's methodology, key findings such as dose-response relationships, and the clinical implications for retina specialists and general ophthalmologists alike, particularly around patient counseling and the potential need for ocular monitoring in patients on these medications.
Kim J, Ahn SJ, Park J, Gower EW, Chung JE. Systemic drugs associated with maculopathy. JAMA Ophthalmol.2025;143(11):946-952. doi:10.1001/jamaophthalmol.2025.3612.
E93- Slit-Lamp Detection of PVD: A Simpler Way to Diagnose- Dr. Mohsin Ali
2025/12/25
In this episode, Dr. Mohsin Ali joins us to discuss his recent study on a simpler and highly effective way to clinically diagnose posterior vitreous detachment (PVD) using slit-lamp visualization of the posterior hyaloid membrane. The study compared this technique to the traditional Weiss ring method and OCT confirmation, finding that slit-lamp assessment of the posterior hyaloid was more sensitive, had a higher negative predictive value, and performed comparably in specificity — without requiring special lenses or imaging. Dr. Ali explains how the technique works, why it matters for everyday practice, and how it can improve decision-making around retinal tears, detachments, and vitreoretinal surgery — making a strong case that this should become a core diagnostic skill for all ophthalmologists.
The instructional slit-lamp PVD video referenced in this episode is available as supplemental material with the original Ophthalmology Retina publication. The video can be found here
References Article:
Sood S, Barra TA, Duong RT, et al.
Non-Funduscopic Slit Lamp Assessment of the Posterior Hyaloid Membrane: A Simpler and More Effective Way of Clinically Diagnosing Posterior Vitreous Detachments.
Ophthalmology Retina. 2025;9(9):892-898. doi:10.1016/j.oret.2025.02.027
E92-3D Heads-up Display Surgery - Dr. David Chow
2025/11/29
Dr. David Chow, a proponent of 3D heads-up display (HUD) surgery for several years and involved in its development, provides a comprehensive introduction to 3D HUD systems in vitreo-retinal surgery. He covers optimization parameters for enhancing resolution and other variables to improve visualization.
E91- Inherited Retinal Disorders- Progress Promise and Lessons— Dr. Ioannis Dimopoulos
2025/10/31
This episode is a reproduction of another Retina-Focused EyeNovation webinar series and a result of a special collaboration between the Canadian Retina Society and the Canadian Ophthalmological Society.
Dr. Ioannis Dimopoulos of the University of Ottawa provides a comprehensive overview of Inherited Retinal Disorders, with a specific focus on various gene therapy approaches. He details the outcomes of his involvement in treatment approaches for Choroideremia.
Dr. Bernard Hurley of the University of Ottawa moderates this webinar.
E90- DRCR Retina Protocol AO- Home OCT for Management of Wet AMD- Dr. Christina Weng
2025/09/13
In this episode of The Retina Channel Podcast, Dr. Christina Weng, Professor of Ophthalmology at Baylor College of Medicine and Chair of DRCR Retina Protocol AO, discusses the pivotal trial evaluating home OCT monitoring in neovascular age-related macular degeneration (AMD). The conversation reviews the study's rationale, methodology, and key findings, with emphasis on how home-based imaging could transform treatment paradigms, refine injection strategies, and inform the future design of retina clinical trials.
E89- Artificial Intelligence Image Analysis and Retina Research- Prof. Ursula Schmidt-Erfurth
2025/08/09
Prof. Schmidt-Erfurth is a Professor and the Past Chair of the Department of Ophthalmology at the Medical University of Vienna and the director of Vienna Reading Centre. She has been a pioneer in the application of AI in retinal image analysis. In this episode, she describes various applications of AI in retina research and the work that her group has been doing over the years. The following article is a review of the some of her work:
Enzendorfer ML, Tratnig-Frankl M, Eidenberger A, Schrittwieser J, Kuchernig L, Schmidt-Erfurth U. Rethinking Clinical Trials in Age-Related Macular Degeneration: How AI-Based OCT Analysis Can Support Successful Outcomes. Pharmaceuticals (Basel). 2025 Feb 20;18(3):284. doi: 10.3390/ph18030284. PMID: 40143063; PMCID: PMC11945239.
E88- SIRE sign, Geographic Atrophy trials and treatments- Prof. Robyn Guymer
2025/06/28
This episode is another retina-focused EyeNovation episode featuring Prof. Robyn Guymer who presented an in-depth discussion on the SIRE sign, assessment of visual function in Geographic atrophy and also current GA trials and treatments.
YouTube link: https://youtu.be/p-R4_OsuGKE
E87- Pachychoroid Disease Spectrum- A deep Dive- Dr. Angie Fong
2025/05/16
This episode is a reproduction of the second retina-focused EyeNovation webinar series and a result of a special collaboration between Canadian Retina Society and Canadian Ophthalmological Society.
Dr. Angie Fong from the University of Hong Kong gives a fantastic overview of pachychoroid spectrum of conditions with a focus on central serous chorioretinopathy and polypoidal choroidal vasculopathy. She gives an in-depth review of pathogenesis, recent clinical trials, and emerging management strategies and discussed the incidence and risk factors for PDS progression based on natural observation studies.
Dr. Wai-Ching Lam from the University of British Columbia is the moderator for this webinar.
E86-8-Year Cognitive Outcomes of Intravitreal Bevacizumab for ROP- Dr. Wei-Chi Wu
2025/04/15
Dr. Wu discusses prospective cognitive outcomes of children who had treatment for Retinopathy of Prematurity. The analysis suggests that cognitive outcomes were similar for children who had either laser or anti-VEGF injections for ROP treatment.
Dr. Wu will be one of the invited guest speakers at the Canadian Retina Society meeting in Vancouver, BC from April 25-April 27, 2025. You can register for this meeting at:
https://crsscr.ca/meeting
Discussed article:
Wu PL, Shih CP, Huang YS, Chen HC, Hsueh YJ, Lee CW, Chiang MC, Lien R, Lee CC, Chu SM, Chou HD, Liu L, Chen KJ, Hwang YS, Lai CC, Wu WC. ADMINISTERING INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY: 8-Year Cognitive Outcomes In A Prospective Cohort. Retina. 2024 Nov 1;44(11):1952-1960. doi: 10.1097/IAE.0000000000004222. PMID: 39121508.
E85-EyeNovation Webinar- Double Layer Sign- Dr. Usha Chakravarthy
2025/03/09
This episode is a recording of the retina-focused EyeNovation webinar episode which was a collaboration between Canadian Ophthalmological Society and the Canadian Retina Society. Dr. Chakravarthy will provide a background to the double layer sign, its definition and how it is detected. Data to support the presentation will be from the EDNA trial . This study possesses an imaging dataset that was captured longitudinally in over 500 high risk eyes and obtained robust rates of progression to neovascularization as well as time to the event. The presence of the DLS and or other features of intermediate AMD were assessed at baseline and included measurements of length of separation of the RPE from its basement membrane, height of separation and the number of B scans involved. Rates of progression in eyes without and with DLS were computed and models built to assess risk of progression to neovascularization. In addition the DLS and SIRE signs were compared for their contributions to risk of progression. The findings from these analyses and their clinical significance will be discussed .
Make sure to register for the Canadian Retina Society (CRS) annual meeting which will take place in Vancouver, BC from April 25-27, 2025. Go to https://www.crsscr.ca to register.
Podcast sponsorship advertising
Start advertising on The Retina Channel Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.897081456
The Graham Allen Show
Graham Allen

4.7106622000
FantasyPros - Fantasy Football Podcast
iHeartPodcasts

4.6253972000
The Glenn Beck Program
Mercury Radio Arts

4.8224901808
The Andrew Klavan Show
The Daily Wire

4.6652782197
The Charlie Kirk Show
Charlie Kirk

4.930902000
The Quote of the Day Show | Daily Motivational Talks
Sean Croxton

4.6432911273
Verdict with Ted Cruz
Premiere Networks

4.762612000
The Lawfare Podcast
The Lawfare Institute

4.7278922000
The Matt Walsh Show
The Daily Wire

4.818422000
The Cabral Concept
Dr. Stephen Cabral